SEARCH

SEARCH BY CITATION

References

  • 1
    Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10. Lyon: International Agency for Research on Cancer, 2010. [Cited 14 Apr 2011.] Available from URL: http://globocan.iarc.fr/
  • 2
    Ferlay J, Parkin DM, Curado MP et al. Cancer Incidence in Five Continents, Volumes I–IX: IARC CancerBase No. 9. Lyon: International Agency for Research on Cancer, 2010. [Cited 14 Apr 2011.] Available from URL: http://ci5.iarc.fr
  • 3
    Ferlay J. World Health Organization, Mortality Database. [Cited 7 Jan 2010.] Available from URL: http://www.who.int/whosis/whosis/
  • 4
    Hirabayashi Y, Zhang M. Comparison of time trends in breast cancer incidence (1973–2002) in Asia, from cancer incidence in five continents, Vols IV–IX. Jpn J Clin Oncol 2009; 39: 41112.
  • 5
    Shin HR, Boniol M, Joubert C et al. Secular trends in breast cancer mortality in five East Asian populations: Hong Kong, Japan, Korea, Singapore and Taiwan. Cancer Sci 2010; 101: 12416.
  • 6
    Matsuda T, Marugame T, Kamo K, Katanoda K, Ajiki W, Sobue T. Cancer incidence and incidence rates in Japan in 2005: based on data from 12 population-based cancer registries in the monitoring of cancer incidence in Japan (MCIJ) project. Jpn J Clin Oncol 2011; 41: 13947.
  • 7
    Statistics and Information Department. Minister’s Secretariat. Ministry of Health, Labor and Welfare. Vital Statistics of Japan. 1958–2005. Tokyo: Health and Welfare Statistics Association.
  • 8
    Jatoi I, Miller AB. Why is breast-cancer mortality declining? Lancet Oncol 2003; 4: 2514.
  • 9
    Kumle M. Declining breast cancer incidence and decreased HRT use. Lancet 2008; 372: 60810.
  • 10
    Yoshiike N, Seino F, Tajima S et al. Twenty-year changes in the prevalence of overweight in Japanese adults: the national nutrition survey 1976–95. Obes Rev 2002; 3: 18390.
  • 11
    Nagata C, Matsushita Y, Shimizu H. Prevalence of hormone replacement therapy and user’s characteristics: a community survey in Japan. Maturitas 1996; 25: 2017.
  • 12
    Shimizu H, Ross RK, Bernstein L, Yatani R, Henderson BE, Mack TM. Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles county. Br J Cancer 1991; 63: 9636.
  • 13
    Tsugane S, de Souza JM, Costa ML Jr et al. Cancer incidence rates among Japanese immigrants in the city of Sao Paulo, Brazil, 1969–78. Cancer Causes Control 1990; 1: 18993.
  • 14
    Iwasaki M, Mameri CP, Hamada GS, Tsugane S. Secular trends in cancer mortality among Japanese immigrants in the state of Sao Paulo, Brazil, 1979–2001. Eur J Cancer Prev 2008; 17: 18.
  • 15
    Key TJ, Verkasalo PK, Banks E. Epidemiology of breast cancer. Lancet Oncol 2001; 2: 13340.
  • 16
    AdamiHO, HunterDJ, TrichopolosD (eds). Textbook of Cancer Epidemiology, 2nd edn. New York: Oxford University Press, 2008.
  • 17
    Schottenfeld D, Fraumeni JF (eds). Cancer Epidemiology and Prevention, 3rd edn. New York: Oxford University Press, 2006.
  • 18
    Key T, Appleby P, Barnes I, Reeves G. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 2002; 94: 60616.
  • 19
    Henderson BE, Feigelson HS. Hormonal carcinogenesis. Carcinogenesis 2000; 21: 42733.
  • 20
    Tsugane S, Sobue T. Baseline survey of JPHC study: design and participation rate. Japan public health center-based prospective study on cancer and cardiovascular diseases. J Epidemiol 2001; 11(Suppl): S249.
  • 21
    Iwasaki M, Hamada GS, Nishimoto IN et al. Dietary isoflavone intake and breast cancer risk in case–control studies in Japanese, Japanese Brazilians, and non-Japanese Brazilians. Breast Cancer Res Treat 2009; 116: 40111.
  • 22
    Nagata C, Hu YH, Shimizu H. Effects of menstrual and reproductive factors on the risk of breast cancer: meta-analysis of the case–control studies in Japan. Jpn J Cancer Res 1995; 86: 91015.
  • 23
    Iwasaki M, Otani T, Inoue M, Sasazuki S, Tsugane S. Role and impact of menstrual and reproductive factors on breast cancer risk in Japan. Eur J Cancer Prev 2007; 16: 11623.
  • 24
    World Cancer Research Fund and American Institute for Cancer Research. Food, Nutrition, Physical Activity and the Prevention of Cancer: A Global Perspective. Washington, DC: American Institute for Cancer Research, 2007.
  • 25
    Yang XR, Chang-Claude J, Goode EL et al. Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the breast cancer association consortium studies. J Natl Cancer Inst 2011; 103: 25063.
  • 26
    Iwasaki M, Otani T, Inoue M, Sasazuki S, Tsugane S. Body size and risk for breast cancer in relation to estrogen and progesterone receptor status in Japan. Ann Epidemiol 2007; 17: 30412.
  • 27
    Potischman N, Swanson CA, Siiteri P, Hoover RN. Reversal of relation between body mass and endogenous estrogen concentrations with menopausal status. J Natl Cancer Inst 1996; 88: 7568.
  • 28
    Suzuki R, Iwasaki M, Inoue M et al. Body weight at age 20 years, subsequent weight change and breast cancer risk defined by estrogen and progesterone receptor status: the Japan public health center-based prospective study. Int J Cancer 2010; DOI: 10.1002/ijc.25744. [Epub ahead of print.]
  • 29
    Kuriyama S, Tsubono Y, Hozawa A et al. Obesity and risk of cancer in Japan. Int J Cancer 2005; 113: 14857.
  • 30
    Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008; 371: 56978.
  • 31
    Suzuki R, Orsini N, Saji S, Key TJ, Wolk A. Body weight and incidence of breast cancer defined by estrogen and progesterone receptor status: a meta-analysis. Int J Cancer 2009; 124: 698712.
  • 32
    Monninkhof EM, Elias SG, Vlems FA et al. Physical activity and breast cancer: a systematic review. Epidemiology 2007; 18: 13757.
  • 33
    Hoffman-Goetz L, Apter D, Demark-Wahnefried W, Goran MI, McTiernan A, Reichman ME. Possible mechanisms mediating an association between physical activity and breast cancer. Cancer 1998; 83: 6218.
  • 34
    Suzuki R, Iwasaki M, Yamamoto S et al. Leisure-time physical activity and breast cancer risk defined by estrogen and progesterone receptor status: the Japan public health center-based prospective study. Prev Med 2011; 52: 22733.
  • 35
    Suzuki R, Iwasaki M, Kasuga Y et al. Leisure-time physical activity and breast cancer risk by hormone receptor status: effective life periods and exercise intensity. Cancer Causes Control 2010; 21: 178798.
  • 36
    Suzuki S, Kojima M, Tokudome S et al. Effect of physical activity on breast cancer risk: findings of the Japan collaborative cohort study. Cancer Epidemiol Biomarkers Prev 2008; 17: 3396401.
  • 37
    Suzuki R, Iwasaki M, Inoue M et al. Alcohol consumption-associated breast cancer incidence and potential effect modifiers: the Japan public health center-based prospective study. Int J Cancer 2010; 127: 68595.
  • 38
    Nagata C, Mizoue T, Tanaka K et al. Alcohol drinking and breast cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population. Jpn J Clin Oncol 2007; 37: 56874.
  • 39
    Singletary KW, Gapstur SM. Alcohol and breast cancer: review of epidemiologic and experimental evidence and potential mechanisms. JAMA 2001; 286: 214351.
  • 40
    Suzuki R, Orsini N, Mignone L, Saji S, Wolk A. Alcohol intake and risk of breast cancer defined by estrogen and progesterone receptor status: a meta-analysis of epidemiological studies. Int J Cancer 2008; 122: 183241.
  • 41
    Michels KB, Terry KL, Willett WC. Longitudinal study on the role of body size in premenopausal breast cancer. Arch Intern Med 2006; 166: 2395402.
  • 42
    Weiderpass E, Braaten T, Magnusson C et al. A prospective study of body size in different periods of life and risk of premenopausal breast cancer. Cancer Epidemiol Biomarkers Prev 2004; 13: 11217.
  • 43
    Ahn J, Schatzkin A, Lacey JV Jr et al. Adiposity, adult weight change, and postmenopausal breast cancer risk. Arch Intern Med 2007; 167: 2091102.
  • 44
    Kawai M, Minami Y, Kuriyama S et al. Adiposity, adult weight change and breast cancer risk in postmenopausal Japanese women: the Miyagi Cohort study. Br J Cancer 2010; 103: 14437.
  • 45
    Adlercreutz H. Epidemiology of phytoestrogens. Baillieres Clin Endocrinol Metab 1998; 12: 60523.
  • 46
    Yamamoto S, Sobue T, Kobayashi M, Sasaki S, Tsugane S. Soy, isoflavones, and breast cancer risk in Japan. J Natl Cancer Inst 2003; 95: 90613.
  • 47
    Iwasaki M, Inoue M, Otani T et al. Plasma isoflavone level and subsequent risk of breast cancer among Japanese women: a nested case–control study from the Japan public health center-based prospective study group. J Clin Oncol 2008; 26: 167783.
  • 48
    Trock BJ, Hilakivi-Clarke L, Clarke R. Meta-analysis of soy intake and breast cancer risk. J Natl Cancer Inst 2006; 98: 45971.
  • 49
    Wu AH, Yu MC, Tseng CC, Pike MC. Epidemiology of soy exposures and breast cancer risk. Br J Cancer 2008; 98: 914.
  • 50
    Limer JL, Speirs V. Phyto-oestrogens and breast cancer chemoprevention. Breast Cancer Res 2004; 6: 11927.
  • 51
    Kuiper GG, Lemmen JG, Carlsson B et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 1998; 139: 425263.
  • 52
    Brooks JD, Thompson LU. Mammalian lignans and genistein decrease the activities of aromatase and 17beta-hydroxysteroid dehydrogenase in MCF-7 cells. J Steroid Biochem Mol Biol 2005; 94: 4617.
  • 53
    Mousavi Y, Adlercreutz H. Genistein is an effective stimulator of sex hormone-binding globulin production in hepatocarcinoma human liver cancer cells and suppresses proliferation of these cells in culture. Steroids 1993; 58: 3014.
  • 54
    Iwasaki M, Hamada GS, Nishimoto IN et al. Isoflavone, polymorphisms in estrogen receptor genes and breast cancer risk in case–control studies in Japanese, Japanese Brazilians and non-Japanese Brazilians. Cancer Sci 2009; 100: 92733.
  • 55
    Iwasaki M, Hamada GS, Nishimoto IN et al. Dietary isoflavone intake, polymorphisms in the CYP17, CYP19, 17beta-HSD1, and SHBG genes, and risk of breast cancer in case–control studies in Japanese, Japanese Brazilians, and non-Japanese Brazilians. Nutr Cancer 2010; 62: 46675.
  • 56
    Nagata C. Factors to consider in the association between soy isoflavone intake and breast cancer risk. J Epidemiol 2010; 20: 839.
  • 57
    Yang CS, Lambert JD, Sang S. Antioxidative and anti-carcinogenic activities of tea polyphenols. Arch Toxicol 2009; 83: 1121.
  • 58
    Komori A, Yatsunami J, Okabe S et al. Anticarcinogenic activity of green tea polyphenols. Jpn J Clin Oncol 1993; 23: 18690.
  • 59
    Iwasaki M, Inoue M, Sasazuki S et al. Green tea drinking and subsequent risk of breast cancer in a population to based cohort of Japanese women. Breast Cancer Res 2010; 12: R88.
  • 60
    Iwasaki M, Inoue M, Sasazuki S et al. Plasma tea polyphenol levels and subsequent risk of breast cancer among Japanese women: a nested case–control study. Breast Cancer Res Treat 2010; 124: 82734.
  • 61
    Shrubsole MJ, Lu W, Chen Z et al. Drinking green tea modestly reduces breast cancer risk. J Nutr 2009; 139: 31016.
  • 62
    Zhang M, Holman CD, Huang JP, Xie X. Green tea and the prevention of breast cancer: a case–control study in Southeast China. Carcinogenesis 2007; 28: 10748.
  • 63
    Wu AH, Yu MC, Tseng CC, Hankin J, Pike MC. Green tea and risk of breast cancer in Asian Americans. Int J Cancer 2003; 106: 5749.
  • 64
    Nagano J, Kono S, Preston DL, Mabuchi K. A prospective study of green tea consumption and cancer incidence, Hiroshima and Nagasaki (Japan). Cancer Causes Control 2001; 12: 5018.
  • 65
    Suzuki Y, Tsubono Y, Nakaya N, Koizumi Y, Tsuji I. Green tea and the risk of breast cancer: pooled analysis of two prospective studies in Japan. Br J Cancer 2004; 90: 13613.
  • 66
    Inoue M, Robien K, Wang R, Van Den Berg DJ, Koh WP, Yu MC. Green tea intake, MTHFR/TYMS genotype and breast cancer risk: the Singapore Chinese Health Study. Carcinogenesis 2008; 29: 196772.
  • 67
    Dai Q, Shu XO, Li H et al. Is green tea drinking associated with a later onset of breast cancer? Ann Epidemiol 2010; 20: 7481.
  • 68
    Luo J, Gao YT, Chow WH et al. Urinary polyphenols and breast cancer risk: results from the Shanghai Women’s Health Study. Breast Cancer Res Treat 2010; 120: 693702.
  • 69
    Hanaoka T, Yamamoto S, Sobue T, Sasaki S, Tsugane S. Active and passive smoking and breast cancer risk in middle-aged Japanese women. Int J Cancer 2005; 114: 31722.
  • 70
    Nagata C, Mizoue T, Tanaka K et al. Tobacco smoking and breast cancer risk: an evaluation based on a systematic review of epidemiological evidence among the Japanese population. Jpn J Clin Oncol 2006; 36: 38794.
  • 71
    International Agency for Research on Cancer. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, vol. 83: Tobacco Smoke and Involuntary Smoking. Lyon: IARC Press, 2004.
  • 72
    Collishaw NE, Boyd NF, Cantor KP et al. Canadian Expert Panel on Tobacco Smoke and Breast Cancer Risk. Toronto, Canada: Ontario Tobacco Research Unit, OTRU Special Report Series, 2009.
  • 73
    Ambrosone CB, Kropp S, Yang J, Yao S, Shields PG, Chang-Claude J. Cigarette smoking, N-acetyltransferase 2 genotypes, and breast cancer risk: pooled analysis and meta-analysis. Cancer Epidemiol Biomarkers Prev 2008; 17: 1526.
  • 74
    Secretan B, Straif K, Baan R et al. A review of human carcinogens. part E: tobacco, areca nut, alcohol, coal smoke, and salted fish. Lancet Oncol 2009; 10: 10334.
  • 75
    Miller MD, Marty MA, Broadwin R et al. The association between exposure to environmental tobacco smoke and breast cancer: a review by the California environmental protection agency. Prev Med 2007; 44: 93106.
  • 76
    Pirie K, Beral V, Peto R, Roddam A, Reeves G, Green J. Passive smoking and breast cancer in never smokers: prospective study and meta-analysis. Int J Epidemiol 2008; 37: 106979.